HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryan Lupo Selected Research

Therapeutics

10/2020Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence.
1/2020NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryan Lupo Research Topics

Disease

5Neoplasms (Cancer)
11/2020 - 10/2018
4Breast Neoplasms (Breast Cancer)
11/2020 - 10/2018
2Residual Neoplasm
10/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
11/2020 - 10/2018
1Histone MethyltransferasesIBA
11/2020
1AntioxidantsIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2020
1CollagenIBA
01/2019
1CytokinesIBA
01/2019

Therapy/Procedure

2Therapeutics
10/2020 - 01/2020
1Drug Therapy (Chemotherapy)
10/2018